Adding Auricular Acupuncture to Xiao-Feng-San Decoction for Treating Atopic Dermatitis (NCT06492902) | Clinical Trial Compass
CompletedNot Applicable
Adding Auricular Acupuncture to Xiao-Feng-San Decoction for Treating Atopic Dermatitis
Vietnam156 participantsStarted 2024-07-15
Plain-language summary
This study aims to compare the efficacy of adding auricular acupuncture to Xiao-Feng-San decoction versus Xiao-Feng-San decoction in treating atopic dermatitis. The trial is a multi-center, double-blinded, randomized, sham-controlled study.
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Diagnosed with atopic dermatitis (AD) according to the American Academy of Dermatology guidelines and classified as mild to moderate.
* Classified under Traditional Medicine as exhibiting wind-dampness-heat manifestations and prescribed Xiao-Feng-San decoction.
* Voluntary informed consent.
Exclusion Criteria:
* Presence of other active skin diseases or skin infections requiring systemic treatment within the past four weeks or that would interfere with the proper assessment of atopic dermatitis lesions.
* Use of systemic therapy for AD, including but not limited to corticosteroids, methotrexate, cyclosporine, azathioprine, phosphodiesterase type 4 (PDE4) inhibitors, interferon-gamma (IFN-γ), and mycophenolate mofetil within the past four weeks.
* Use of targeted biologic treatments within the past five half-lives (if known) or within the past 12 weeks, whichever is longer.
* Use of phototherapy treatment, laser therapy, tanning booth sessions, or extended sun exposure that could affect disease severity or interfere with disease assessments within the past four weeks.
* Use of systemic anti-infectives within the past four weeks.
* Use of herbal medicine within the past 12 weeks.
* Use of topical treatments for AD, including but not limited to topical corticosteroids (TCS), topical calcineurin inhibitors (TCIs), or topical phosphodiesterase-4 (PDE-4) inhibitors within the past one week.
* History of alcohol or substance addiction within the past six mon…
What they're measuring
1
Changes in Scoring Atopic Dermatitis (SCORAD) score
Timeframe: At randomization and weekly throughout the four-week period (Week 0, Week 1, Week 2, Week 3, Week 4)
Trial details
NCT IDNCT06492902
SponsorUniversity of Medicine and Pharmacy at Ho Chi Minh City